Dr Reddy's shares gain after Canada nod for semaglutide; marking first G7 approval
Dr Reddy's shares gain after Canada nod for semaglutide; marking first G7 approval
Dr Reddy's shares gain after Canada nod for semaglutide; marking first G7 approval
Sector
HEALTHCARE
News Type
MARKET
Impact Level
MEDIUM
AI Sentiment
POSITIVE
Published
03 May 2026
📎 Sources
CNBC TV18 | https://www.tradingview.com/news/cnbctv:bb6a8d2fc094b:0/